ModelEdge

Pear Therapeutics Inc.

Filing Type	10-K
Filing Date	3/30/2023
Updated	3/31/23, 10:01 AM

Filing

Earnings Release

Exhibits

EX-10.34EX-10.34 - SEPARATION AGREEMENT

EX-10.35EX-10.35 - FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT

EX-10.36EX-10.36 - FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

EX-23.1EX-23.1 - DT CONSENT

EX-31.1EX-31.1 CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A)

EX-31.2EX-31.2 CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A)